Table 3.
AOR | 95% CI | P value | Sig. | |
---|---|---|---|---|
Age Group | ||||
18–44 | 0.56 | [0.32, 0.97] | 0.027 | *** |
45–54 | 0.73 | [0.49, 1.07] | 0.083 | |
55–64 | 0.93 | [0.66, 1.32] | 0.636 | |
>65 (Ref.) | ||||
Gender | ** | |||
Women | 0.64 | [0.47, 0.87] | 0.003 | |
Men (Ref.) | ||||
Marital Status | ||||
Single | 0.56 | [0.32, 0.98] | 0.051 | |
Married (Ref.) | ||||
Nationality | ||||
Non-Saudi | 0.78 | [0.48, 1.28] | 0.308 | |
Saudi (Ref.) | ||||
Hypertension | ||||
Yes | 1.20 | [0.89, 1.62] | 0.138 | |
No (Ref.) | ||||
Asthma | ||||
Yes | 0.95 | [0.60, 1.49] | 0.892 | |
No (Ref.) | ||||
Osteoarthritis | ||||
Yes | 0.78 | [0.48, 1.27] | 0.307 | |
No (Ref.) | ||||
Osteoporosis | ||||
Yes | 1.15 | [0.58, 2.26] | 0.719 | |
No (Ref.) | ||||
Anxiety | ||||
Yes | 0.60 | [0.33, 1.08] | 0.114 | |
No (Ref.) | ||||
Depression | ||||
Yes | 0.54 | [0.23, 1.24] | 0.155 | |
No (Ref.) | ||||
Polypharmacy | * | |||
≥5 | 0.67 | [0.47, 0.96] | 0.011 | |
0 to 4 drugs | ||||
LDL goal attainment | ||||
Yes | 1.27 | [0.97, 1.66] | 0.726 | |
No |
Notes: *Study Population Comprised of 1532 People with type 2 diabetes and dyslipidemia who Visited Outpatient’s Clinics from Tertiary Hospital. Asterisks (*) represent significant differences based on statin adherence from logistic regressions with poor adherence as the reference group. ***P< 0.001; **0.001 ≤ p < 0.01; *0.01 ≤ p < 0.05.
Abbreviations: AOR, Adjusted Odds Ratio; CI, Confidence Interval; Ref, Reference group; Sig, significance.